Insider · CIK 0001791402
Aditya Kohli
Files at HLVX (HilleVax, Inc.). First filing Feb 12, 2024, latest Mar 20, 2024.
In brief
Aditya Kohli files SEC Form 4 as director at HLVX (HilleVax, Inc.). Since Feb 12, 2024, Aditya Kohli has reported 0 open-market buys worth $0 and 5 open-market sells worth $829k, the latest filed on Mar 20, 2024.
A track record needs three past buys with six months of prices behind them; Aditya Kohli has 0, so none is measured yet.
The newest scored trade: sold $986M of HLVX on Mar 18, 2024, filed Mar 20, 2024, scored 20 (weak), under a 10b5-1 plan.
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 20Weak | HilleVax, Inc. | $986M 18,000 shares | -2% | - | |
| 10Weak | HilleVax, Inc. | $336k 18,000 shares | -2% | - | |
| 23Weak | HilleVax, Inc. | $269k 18,000 shares | -2% | - | |
| 19Weak | HilleVax, Inc. | $92k 6,000 shares | -1% | - | |
| 41Moderate | HilleVax, Inc. | $132k 8,866 shares | -1% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Mar 20, 2024 | HLVX HILLEVAX INC | 54,000 0.11% of outstanding | $941k | Mar 20, 2024 | $907k |
| Feb 12, 2024 | HLVX HILLEVAX INC | 54,000 0.11% of outstanding | $810k | Feb 12, 2024 | none |
Transactions
Every row this insider has filed, 15 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 17, 2025 | HLVX HilleVax, Inc. | UTender of shares Common Stock | -698,171 | - | - | 0 | Sep 17, 2025 |
| Jun 23, 2025 | HLVX HilleVax, Inc. | AGrant or award Common Stock | +17,199 | $0.00 | $0 | 698,171 | Jun 25, 2025 |
| Mar 18, 2024 | HLVX HilleVax, Inc. | SOpen-market sale Common Stock10b5-1 | -6,000 | $17.66 | $106k | 819,776 | Mar 20, 2024 |
| Mar 19, 2024 | HLVX HilleVax, Inc. | SOpen-market sale Common Stock10b5-1 | -6,000 | $17.42 | $104k | 813,776 | Mar 20, 2024 |
| Mar 20, 2024 | HLVX HilleVax, Inc. | SOpen-market sale Common Stock10b5-1 | -6,000 | $164,221.00 | $985M | 807,776 | Mar 20, 2024 |
| Mar 6, 2024 | HLVX HilleVax, Inc. | SOpen-market sale Common Stock10b5-1 | -6,000 | $18.95 | $114k | 837,776 | Mar 8, 2024 |
| Mar 7, 2024 | HLVX HilleVax, Inc. | SOpen-market sale Common Stock10b5-1 | -6,000 | $18.37 | $110k | 831,776 | Mar 8, 2024 |
| Mar 8, 2024 | HLVX HilleVax, Inc. | SOpen-market sale Common Stock10b5-1 | -6,000 | $18.66 | $112k | 825,776 | Mar 8, 2024 |
| Feb 20, 2024 | HLVX HilleVax, Inc. | SOpen-market sale Common Stock10b5-1 | -6,000 | $14.88 | $89k | 855,776 | Feb 22, 2024 |
| Feb 21, 2024 | HLVX HilleVax, Inc. | SOpen-market sale Common Stock10b5-1 | -6,000 | $14.92 | $89k | 849,776 | Feb 22, 2024 |
| Feb 22, 2024 | HLVX HilleVax, Inc. | SOpen-market sale Common Stock10b5-1 | -6,000 | $15.05 | $90k | 843,776 | Feb 22, 2024 |
| Feb 12, 2024 | HLVX HilleVax, Inc. | SOpen-market sale Common Stock10b5-1 | -6,000 | $15.32 | $92k | 861,776 | Feb 14, 2024 |
| Feb 8, 2024 | HLVX HilleVax, Inc. | SOpen-market sale Common Stock | -8,866 | $14.93 | $132k | 812,878 | Feb 12, 2024 |
| Feb 8, 2024 | HLVX HilleVax, Inc. | AGrant or award Common Stock | +54,898 | $0.00 | $0 | 867,776 | Feb 12, 2024 |
| Feb 8, 2024 | HLVX HilleVax, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +71,500 | $0.00 | $0 | 71,500 | Feb 12, 2024 |
Questions about Aditya Kohli
Answered from the filings on this page, as of the latest one.
Is Aditya Kohli buying or selling?
Not in the last 12 months. Aditya Kohli's latest open-market trade on SEC Form 4 was sold $986M of HLVX on Mar 18, 2024.
How did Aditya Kohli's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Aditya Kohli has 0.
Where does Aditya Kohli file Form 4?
Aditya Kohli has filed Form 4 at HLVX (HilleVax, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.